Nam Ha Pharmaceutical

What Nam Ha Pharmaceutical does

Nam Ha Pharmaceutical (Dược Nam Hà) is a 65-year-old Vietnamese pharmaceutical manufacturer headquartered in Nam Định with production operations centered in Ninh Bình province. The company operates as a Công ty Cổ phần (Joint Stock Company) with approximately 1,000 employees and manufactures a portfolio of roughly 200 modern pharmaceutical products (tân dược), traditional Eastern medicines (đông dược), health supplements (thực phẩm bảo vệ sức khỏe), cosmetics, and medical equipment. Core products include the Bổ Phế Nam Hà respiratory care line (cough syrup, lozenges, throat sprays for adults and children), Coldi-B nasal spray, Skinbibi children's skincare, and X-Tri hemorrhoid cream.

Manufacturing is conducted across two WHO-GMP certified facilities — Factory 1 (8 modern drug production lines, 4 health supplement lines) and Factory 2 (3 traditional medicine lines, 1 herbal processing line) — supported by a WHO-GSP certified multi-regional warehouse network and GACP-WHO certified medicinal herb cultivation zones in northern mountainous regions including Bắc Hà and Bát Xát in Lào Cai. The company has announced a 300-hectare national medicinal plant cultivation project in Điện Biên with planned investment of 450 billion VND.

Revenue is generated primarily through a hybrid go-to-market model combining OTC distribution across over 30,000 pharmacies in all 63 Vietnamese provinces via 6 regional branch offices and dedicated field sales representatives, plus an ETC (hospital/ethical) channel for prescription products including anti-tuberculosis medications, contract manufacturing (OEM) leveraging excess production capacity, and international exports to Laos, Cambodia, Myanmar, Russia, Bangladesh, and Africa. Disclosed revenue reached 1,004 billion VND in 2023 and 1,107.2 billion VND in 2025, with after-tax profit of 51.4 billion VND in 2025 (up 51.2% YoY). The company has been consecutively ranked in Vietnam's Top 500 Largest Enterprises (VNR500) for 12 years and Top 5 Most Reputable Eastern Medicine Companies for 6 consecutive years, and operates under CEO Hà Thanh Thủy.

Name

Nam Ha Pharmaceutical

Legal name

Công ty Cổ phần Dược phẩm Nam Hà

Website

https://namhapharma.com

Company type

Private

Founded year

1960

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Nam Ha Pharmaceutical is a 65-year-old Vietnamese pharmaceutical manufacturer producing modern medicines, traditional Eastern medicines, health supplements, and cosmetics through WHO-GMP certified facilities, distributed via over 30,000 pharmacies across all 63 provinces and exported to regional markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Respiratory & Allergy Pharmaceuticals (HLAIAAAH)

akta.pro secondary industries

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF)

Keywords

• Pharmaceutical manufacturing
• Traditional Eastern medicine
• Health supplements
• Contract manufacturing
• OTC pharmaceuticals

Headquarters

HQ city

Nam Dinh

HQ country

Vietnam

HQ region

Asia

Offices7 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical and Health Product Sales (Domestic): Sale of modern drugs (tân dược), traditional/Eastern medicines (đông dược), and health supplements (thực phẩm bảo vệ sức khỏe) through OTC (over-the-counter pharmacies) and ETC (hospital/clinical) channels across 63 provinces. Key brands include Bổ Phế Nam Hà, Coldi-B nasal spray, and Skinbibi. Domestic sales constitute the dominant revenue stream. Revenue in 2023: 1,004 billion VND; 2025: 1,107.2 billion VND.
2. Contract Manufacturing (OEM/Đối tác gia công): Production services for third-party pharmaceutical companies. The company leverages its WHO-GMP certified facilities and production capacity (628 million units in 2023) to serve contract manufacturing clients.
3. International Export: Export of pharmaceutical products to neighboring and international markets including Laos, Cambodia, Myanmar, Russia, Bangladesh, and Africa. Positioning efforts underway for Japan and European markets.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Core offering

Nam Ha Pharmaceutical manufactures and sells a diversified portfolio of pharmaceutical and consumer health products — including modern Western-style drugs, traditional Eastern (Oriental) medicines, health supplements, cosmetics, and medical equipment — to end consumers through 30,000+ nationwide pharmacies, hospitals via its ETC channel, and as a contract manufacturer for foreign pharmaceutical companies.

Product overview

Nam Ha Pharmaceutical operates as a pharmaceutical manufacturer with a diversified product portfolio spanning modern pharmaceuticals (tân dược), traditional Eastern medicines (đông dược), health supplements (thực phẩm bảo vệ sức khỏe), medical equipment, and cosmetics. The core products include the Bổ Phế Nam Hà respiratory care line (syrup, lozenges, throat sprays for adults and children), Coldi-B nasal spray, Skinbibi children's skincare, and X-tri hemorrhoid cream. The company has developed sub-brands including Bophenamha.vn (respiratory products), Xtri.vn (hemorrhoid products), Skinbibi.com (skincare), and Coldib.vn (nasal spray). Manufacturing is conducted at two WHO-GMP certified facilities in Ninh Binh province, with Factory 1 producing modern pharmaceuticals and health supplements, and Factory 2 specializing in traditional herbal medicines and raw materials. The product portfolio also includes traditional medicines like An Cung Ngưu Hoàng Hoàn, Bổ trung ích khí, Tiêu độc, and Hoàn bổ thận âm, distributed through over 30,000 pharmacies across 63 provinces in Vietnam and exported to international markets including Laos, Cambodia, Myanmar, Russia, Bangladesh, and Africa.

Differentiator

Problem solved

Functional benefit

Brands

• Bổ Phế Nam Hà: Respiratory health product line including syrup, throat lozenges, and spray for cough relief. The flagship brand launched in 1960, recognized as a National Brand of Vietnam multiple times.
• Skinbibi
• Coldi-B DNH
• X-Tri Nam Hà

Products and services

• Modern Western-style pharmaceutical drugs Modern pharmaceutical medicines (Western-style drugs) manufactured for the Vietnamese domestic market and selected export markets, sold OTC through pharmacies and ETC through hospitals.
• Traditional Eastern (Oriental) medicines Traditional Eastern-medicine products manufactured by Nam Ha, drawing on more than 54 years of brand heritage, distributed via the nationwide pharmacy network.
• Health supplements Health supplement products manufactured by Nam Ha for consumer health maintenance, sold through the nationwide pharmacy distribution network.
• Cosmetics Cosmetic products manufactured by Nam Ha and distributed through the pharmacy network alongside pharmaceutical and supplement lines.
• Medical equipment Medical equipment products supplied by Nam Ha alongside its pharmaceutical and personal-care portfolio via pharmacy and institutional channels.
• Contract pharmaceutical manufacturing services WHO-GMP-compliant contract manufacturing services in which Nam Ha produces pharmaceutical products on behalf of foreign pharmaceutical companies, including the named partner Roche.

Quantifiable outcome

• Top 500 Largest Enterprises in Vietnam for 12 consecutive years (2014–2025)
• +5 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eight partnerships are on record, tiered minor and core.

• Cục Y tế, Bộ Công an (Police Health Department, Ministry of Public Security)minorStrategic or Co-development Partner · 28 June 2026Dược Nam Hà participated in a joint health outreach program with the Police Health Department on June 28, 2026 in Việt Lâm commune, Tuyên Quang province, providing free medical examinations, health consultations, medication distribution, and gifts to local residents.
• Bệnh viện Hữu nghị Việt Nam – Cuba (Vietnam–Cuba Friendship Hospital)coreStrategic or Co-development Partner · 15 May 2026Dược Nam Hà partnered with Vietnam–Cuba Friendship Hospital in the 'Hành trình thanh niên' (Youth Journey) health program from May 15–17, 2026 at Phố Bảng commune, Tuyên Quang province. The company supplied essential medicines and health products for free medical examinations and consultations serving over 200 students and local residents at the Lũng Thầu ethnic minority school.
• Trường Phổ thông Dân tộc bán trú Tiểu học và THCS Lũng Thầu (Lũng Thầu Ethnic Minority Semi-Boarding Primary and Secondary School)minorStrategic or Co-development Partner · 15 May 2026Recipient of healthcare product donations through the 'Hành trình thanh niên' program organized by Vietnam–Cuba Friendship Hospital. Over 200 students received free health checkups and essential healthcare products.
• Bệnh viện Phổi Trung ương / Chương trình Chống lao Quốc gia (National Tuberculosis Control Program / National Lung Hospital)coreStrategic or Co-development Partner · 7 May 2026Dược Nam Hà has partnered with the National Tuberculosis Control Program and National Lung Hospital, supplying anti-tuberculosis medications (single-substance and combination formulations) that meet strict quality standards. The company participated in the program celebration on May 7, 2026 commemorating Dr. Phạm Ngọc Thạch's 117th birthday and reviewing 2025 TB control activities.
• Viện Huyết học – Truyền máu Trung ương (National Institute of Hematology and Blood Transfusion)coreStrategic or Co-development Partner · 30 July 2025Dược Nam Hà partnered with the National Institute of Hematology and Blood Transfusion to organize the 'Hiến máu tình nguyện – Giọt hồng Dược Nam Hà' (Blood Donation – Dược Nam Hà Blood Drop) voluntary blood donation program on July 30, 2025 at the company office. Medical staff from the Institute conducted health checks and oversaw the blood collection process, resulting in 58 units of blood collected.
• Bệnh viện Đại học Y Hà Nội (Hanoi Medical University Hospital)coreStrategic or Co-development Partner · 18 January 2025Dược Nam Hà partnered with Hanoi Medical University Hospital in the 'Xuân biên phòng, ấm lòng dân bản' (New Year Border Patrol, Warming People's Hearts) community health program. The company provided medicines and health products while the hospital's medical team conducted free examinations, consultations, and medication distribution for 400 residents in Chiềng Khừa commune, Mộc Châu, Sơn La province on January 18–19, 2025.
• Cục Quản lý Y Dược cổ truyền, Bộ Y tế / VIETFAIR (Directorate of Traditional Medicine Administration, Ministry of Health / Vietnam Fair and Exhibition Company)coreStrategic or Co-development Partner · 21 November 2024Dược Nam Hà participated as an exhibitor at VIETRAMED EXPO 2024 — the 2nd National Traditional Medicine, Herbal Medicine and Products Fair held November 21–23, 2024 at SECC, Ho Chi Minh City. The company showcased its traditional medicine portfolio and sponsored 1,000 products for free medical consultations organized by the Directorate of Traditional Medicine Administration.
• Quỹ Bảo trợ Trẻ em Việt Nam (Vietnam National Fund for Children)minorStrategic or Co-development Partner · 2 November 2023On November 2, 2023, Dược Nam Hà donated healthcare products to the Vietnam National Fund for Children to support impoverished and disadvantaged children across the country, particularly in advance of the Lunar New Year. The partnership reflects the company's commitment to children's health and welfare.

Scale indicators10 records

Recent moves8 records

Expansion highlights4 records

Market position

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@DuocNamHaOfficial
• Facebookfacebook.com/DuocNamHa
• LinkedInlinkedin.com/company/nam-ha-pharma
• Instagramfacebook.com/DuocNamHa

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nam Ha Pharmaceutical